Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), bought 158 shares at $40.49 ($6K) on 2022-05-13, disclosed to the SEC on 2022-05-17.
Open-market purchase of $6k TXG by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |
| TXG | SELL | 2021-12-15 | $4.2M | — | Filing → |